Upgrade to SI Premium - Free Trial

NextCure Inc. (NXTC)

7.82 -0.02 (0.26%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Form S-4 NextCure, Inc. August 18, 2026 5:30 PM - SEC Filing Form SCHEDULE 13G NextCure, Inc. Filed by: ADAR1 Capital Management, LLC August 14, 2026 9:33 PM - SEC Filing Form SCHEDULE 13G/A NextCure, Inc. Filed by: Ikarian Capital, LLC August 14, 2026 8:58 PM - SEC Filing Form SCHEDULE 13G/A NextCure, Inc. Filed by: Squadron Capital Management LLC August 14, 2026 1:10 PM - SEC Filing Form SCHEDULE 13G/A NextCure, Inc. Filed by: Affinity Asset Advisors, LLC August 13, 2026 4:05 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on NextCure Inc. (NXTC) August 13, 2026 6:59 AM - StreetInsider Form SCHEDULE 13G NextCure, Inc. Filed by: Adage Capital Management, L.P. August 12, 2026 12:07 PM - SEC Filing Form 4 NextCure, Inc. For: Aug 10 Filed by: Simcere Pharmaceutical Group Ltd August 12, 2026 11:35 AM - SEC Filing Form 425 NextCure, Inc. Filed by: NextCure, Inc. August 10, 2026 4:02 PM - SEC Filing Avere Therapeutics raises $500M in private placement for drug program August 10, 2026 7:01 AM - StreetInsider Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 August 10, 2026 7:00 AM - PR NewsWire NextCure Inc. (NXTC) Misses Q2 EPS by 89c August 6, 2026 6:11 PM - StreetInsider Form 10-Q NextCure, Inc. For: Jun 30 August 6, 2026 4:34 PM - SEC Filing Form 8-K NextCure, Inc. For: Aug 06 August 6, 2026 4:22 PM - SEC Filing NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results August 6, 2026 4:01 PM - StreetInsider Form 425 NextCure, Inc. Filed by: NextCure, Inc. August 4, 2026 7:30 AM - SEC Filing Form 4 NextCure, Inc. For: Jul 30 Filed by: Schneeberger Daniel August 3, 2026 5:53 PM - SEC Filing Form 4 NextCure, Inc. For: Jul 27 Filed by: Schneeberger Daniel July 29, 2026 6:19 PM - SEC Filing Form 3 NextCure, Inc. For: Jul 27 Filed by: Schneeberger Daniel July 29, 2026 6:04 PM - SEC Filing Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders July 21, 2026 7:40 AM - StreetInsider Form 425 NextCure, Inc. Filed by: NextCure, Inc. July 16, 2026 5:29 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on NextCure Inc. (NXTC) July 15, 2026 7:41 AM - StreetInsider Form 425 NextCure, Inc. Filed by: NextCure, Inc. July 14, 2026 7:03 AM - SEC Filing Form 8-K NextCure, Inc. For: Jul 14 July 14, 2026 7:01 AM - SEC Filing NextCure and Avere to merge, targeting oral IL-23 therapy July 14, 2026 6:01 AM - StreetInsider NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy July 14, 2026 6:00 AM - StreetInsider Form 8-K NextCure, Inc. For: Jun 18 June 25, 2026 8:01 AM - SEC Filing Form 4 NextCure, Inc. For: Jun 18 Filed by: Borgman Anne Elizabeth June 22, 2026 4:15 PM - SEC Filing Form 4 NextCure, Inc. For: Jun 18 Filed by: Jones Elaine V June 22, 2026 4:15 PM - SEC Filing Form 4 NextCure, Inc. For: Jun 18 Filed by: Feigal Ellen June 22, 2026 4:15 PM - SEC Filing Form 4 NextCure, Inc. For: Jun 18 Filed by: KABAKOFF DAVID S June 22, 2026 4:15 PM - SEC Filing Form 4 NextCure, Inc. For: Jun 18 Filed by: Webster Stephen W June 22, 2026 4:15 PM - SEC Filing Form 4 NextCure, Inc. For: Jun 18 Filed by: Houston John G June 22, 2026 4:15 PM - SEC Filing Full Article List